Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant s
Chiron Corporation has announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of th
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).Patients tak
Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment o
MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapt
New Zealands's Medsafe has sent a letter to all prescribers informing them about new advice relating to the known risks and benefits associated with prescribing medications to treat depression in young people and in adults. The Medicines Advers
MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed pr
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds
Boehringer Ingelheim has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tipranavir. The Company is seeking accelerated
Rosiglitazone, a drug taken to help improve blood sugar levels, also helps boost the effectiveness of a treatment for opening clogged arteries, according to a study in the November issue of Diabetes Care.People who have diabetes are far more li
For a 30 day prescription for Zocor, one beneficiary paid 22 percent less than what he or she would have paid without the Pharmacy Care Alliance discount card, saving $29.46. Zocor is a brand-name cholesterol-lowering drug.
The other beneficiary received a 38 percent discount on a 30 day prescription for lisinopril, a generic drug used to treat high blood pressure and heart failure. He or she paid $5.87 less than the pharmacy would have otherwise charged.
"I encourage seniors to learn more about this important new program, and the discounts available through the Pharmacy Care Alliance card and Medicare," said Mary Ann Wagner, president and consumer health advisor for the Pharmacy Care Alliance. "I want every Medicare beneficiary to understand that savings can be substantial - they can potentially receive $600 from Medicare to use toward the cost of prescriptions."
To locate a neighborhood network pharmacy, enrollees can contact the Pharmacy Care Alliance 24 hours a day, seven days a week by phone at 1-800-PCA-7015 (1-800-722-7015.) (TTY users should call 1-866-735-8556.) Or, they can visit www.PCAcard.com . On the Web site, enrollees can access a consumer-friendly price check feature, enabling them to compare drug prices by pharmacy.